Zimmer CEO sells stock in $150k transaction — 5 key notes

Zimmer CEO David Dvorak sold shares of the company’s stock last week on the open market, according to a Dakota Financial News report.

Advertisement

Here are five things to know about the transaction:

 

• Mr. Dvorak sold 1,300 shares on Tuesday, March 17.
• The average stock price was $115.55.
• The total transaction was $150,215.
• Mr. Dvorak now owns 215,375 shares of Zimmer stock.
• Mr. Dvorak’s stock is valued at around $24 million.

 

There have been several analysts updating the stock’s standing, including Jeffries Group downgrading the stock from “buy” to “hold” and Zacks reiterating a “neutral” rating.

 

More articles on orthopedic devices:
Bacteria-killing orthopedic implants? 5 things to know
Stimwave Technologies to hire 20 new employees
Blue Belt Technologies: 1st Navio-assisted joint procedure completed in Australia

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.